NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
about
WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.Molecular genetics and targeted therapy of WNT-related human diseases (Review).Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.Notum attenuates Wnt/βcatenin signaling to promote tracheal cartilage patterning.From top to bottom: Cell polarity in Hedgehog and Wnt trafficking.Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling.
P2860
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
@en
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
@nl
type
label
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
@en
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
@nl
prefLabel
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
@en
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
@nl
P2093
P2860
P356
P1433
P1476
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition
@en
P2093
Babita Madan
Frois Ashley Oliver
May Ann Lee
Steve Rozen
Zheng Deng Lei
Zhiyuan Ke
P2860
P304
12386-12392
P356
10.18632/ONCOTARGET.7157
P407
P577
2016-03-01T00:00:00Z